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Colors decorate, but also affect, all members of the animal kingdom.
Bees and other insects are attracted by the exquisite colors of flowers in
their search for nectar to make honey. The eyes of the tiny hummingbird
are especially sensitive to red colors so they can find flowers with the
high energy nectars they require. Colors have delighted humans since
prehistoric times. Primitive man used different colored pigments as
ceremonial decorations, as signs of mourning or hostility, and as
decorations on their bodies to advertise their status. They left us proof
of their fascination with colors in the cave paintings found throughout the
world. Every tribe and ethnic group in the world makes exquisitely
colored artifacts, such as masks, banners, and spiritual symbols, as part of
its cultural heritage.
Some of the most brilliant and striking uses of colored inks are
found in the illuminated religious and biblical manuscripts laboriously
prepared by hand in the dark ages. The Renaissance gave rebirth
to the use of color in paintings and frescos. Modern western and artists
and painters like Monet and other French impressionists captured the
very essence and glimmer of color and sunlight in their paintings. Other
artists have used color to establish moods. Johannes Itten, a leading
proponent of the color theory in the Bauhaus school of art established in
Wiemer, Germany, divided colors into warm and cool shades.
He proposed that the manner in which the two types are combined
affects peoples’ perception of them. That colors add so much to our lives
is given banal proof in the difference between a black-white and color
television sets.
It should be no wonder then that in the writings from the most ancient
times, scholarly people have speculated on why and how humans could
be as black as Australian aborigines and Ethiopian warriors or as white as
albinos. The shades of brown, tan, yellow-brown, red-browns observed
in skin or the jet black, browns, yellows, auburns, reds and whites
observed in hair are indeed a remarkable array of colors.
Through the ages, people of different skin colors have been refered as
gods or enslaved as inferiors. Social and economic forces have attached
cultural baggage to skin color not intended by nature. Biologically the
pigment system is an important part of the skin, mucous membrane, eyes,
ears, meninges, and other organs. We will review briefly the history and
growth of our understanding of the pigment system. We arbitrarily have
divided our review into five temporal periods: earliest studies prior to
1900; introduction of the scientific method for the study of pigmentation,
1900–1950; the period of 1950 to 1975; and the modern era from 1975 to
the present. The last section presents a partial list of important questions
that remain topics for study in the future. Hundreds of workers have
made important contributions to this subject. We cannot name all of
them or cite even one work from each in this brief review. We have
attempted to acknowledge as many investigators as possible, and have
included the work on melanocytes most frequently in The Journal of
Investigative Dermatology.
THE EARLIEST STUDIES: PRE-1900
Some of the earliest scientific writings on the source of skin color and
pigment were published in the 17th century by Malphigii for whom the
epidermis was named. (This part of the manuscript was excerpted from SN
Klaus: Some early scientific studies of skin color[1].) Malphigii was
interested in how the skin perceived the sensation of touch. He separated
the dermis and epidermis by allowing a piece of skin obtained from a black
Ethiopian soldier to remain at room temperature overnight. He observed
that between the inner layer (dermis) and outer covering (epidermis), there
was a black mucous-like substance. He believed he identified the cause for
dark skin. His observations were made without the use of a microscope.
John Hunter in the 18th century fixed tissues and was able to dissect
the pigment layer from the skin. This seemed to be definitive proof that a
pigment was present within the epidermis and caused the black coloring
of an individual’s skin. The source of the pigment was unknown. Many
investigators believed that it was an accumulation of bile.
The function of melanin was not known. Many scientists noted that
dark skin seemed to heat more rapidly when exposed to sunlight than
white skin. Benjamin Franklin showed that dark colored cloths laid upon
fresh snow on a bright sunny day melted the underlying ice crystals more
rapidly than light-colored cloth. It was known that black-skinned
individuals normally inhabited tropical regions and that white individuals
came from the north. It seemed perverse to Franklin that nature would
endow individuals living in the tropics with a type of skin which was
inappropriate for the environment. Everard Home resolved this enigma
with a simple but elegant experiment. He exposed both his hands to the
sun. One was covered with a black cloth, the other was left bare. He
measured the temperature of his skin. He found that the black cloth did
indeed elevate the temperature of his skin a few degrees. However, the
exposed hand became sunburned. He concluded that pigment did
indeed cause a slight warming of the skin but protected it from the non-
thermal, i.e., scorching, effects of the sunlight. Thus was born the idea
that melanin was a sunscreen which prevented sunburn, a concept which
persists to the modern age and is only now undergoing reconsideration.
INTRODUCTION OF SCIENTIFIC METHOD: THE
SCIENCE OF PIGMENTATION FROM 1900–1950
The Names of Pigment Cells Terminology for the pigment cell system
was poorly defined before 1950. It was not known which cells were
capable of synthesizing melanin. Melanophages, now known to be
macrophages laden with melanin, were not distinguished from dermal
melanocytes, i.e., true pigment cells found, for example, in Mongolian
spots. By 1950, there was a consensus that melanin producing cells
should be called melanoblasts, and non-melanin producing cells called
melanophores. This terminology was changed after 1950 [2].
The Embryonic Origin of Pigment Cells In 1934, G. P. Du-Shane
published the first evidence that melanoblasts in the axolotl came from
the neural crest. Because lower vertebrates had a duplicate pigmentary
system in their skin, one in the dermis and the second in the epidermis,
the applicability of this observation to mammals was debated. By 1940,
Mary Rawles had published definitive results from experiments in which
the neural tube was exterpolated and explanted that convinced all
skeptics that melanocytes in vertebrates also were neural crest derivatives
[3]. That concept is still regarded as dogma today.
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The Melanin Producing Cell: Melanoblast Bruno Bloch, a Swiss
dermatologist, in 1917 described the dopa (dihydroxy phenylalanine)
reaction for the identification of melanoblasts. A positive dopa test was
considered proof that a cell was capable of synthesizing melanin. Bloch
and others thought dopa was the primary substrate for the production of
melanin and was delivered by the blood. Pierre Masson later found that
melanin reduced silver ions, especially if it was dissolved in an
ammonium nitrate solution. These early investigators used unfixed, often
very thick sections. The techniques did not produce high resolution and
the results were difficult to interpret. Prior to 1950, everyone agreed that
melanin was found in greatest quantity in the basal layer of the
epidermis. It was the general impression that basal keratinocytes, as well
as melanoblasts, synthesized melanin. That melanoblasts were dendritic
and were exclusively responsible for the production of melanin was not
unequivocally agreed on until the work of Becker was published. Becker
stained paraffin-embedded tissues which could be cut into relatively thin
(5mm) sections. He was able to delineate dopa positive pigment cells
from keratinocytes more precisely. He concluded that melanin was
transferred from melanocytes into surrounding keratinocytes. These
points are now universally accepted. Billingham found that melanocytes
were capable of dividing within the skin [4]. Most investigators believed
the Langerhans cell to be a dying melanocyte. However, Merkel cells
were considered to be an entirely different cell type.
The Melanin Pathway Bruno Bloch and others thought that dopa was
the primary substrate for melanin. H. S. Raper identified the enzyme
tyrosinase in several plants. The plant enzyme converted tyrosine as well
as dopa to melanin. However, human epidermis was not known to
contain the tyrosinase enzyme. Thus Raper’s work was considered not to
be applicable to human skin. Billingham later showed that human skin
did indeed contain a tyrosinase enzyme [3]. He also suggested that
tyrosine, not dopa, was probably the primary substrate for melanin. Raper
also described the basic steps in the conversion of tyrosine to melanin
through which tyrosine is first oxidized to dopa, to dopaquninone, and
then through a series of intermediates which finally condense into the
polymer called melanin. Mason modified details of the pathway, but the
general outlines of the synthesis proposed by these two investigators
remain valid today.
The Melanin Molecule Mason in 1948 divided the types of melanin
into animal, plant, and synthetic forms. Melanin visualized by light
microscopy appeared granular. The fact that pigment was contained
within melanosomes was unknown. The two types of pigments,
eumelanin and phaeomelanin, were not distinguished. Whether synthetic
and natural melanin were similar was debated. Melanin was considered
to be a polymer [2,3]. Whether it was composed of identical subunits
(homopolymer) or a potpourri of different compounds (heteropolymer)
was heatedly disputed. Harold Bloom suggested that melanin was a very
poor sunscreen and that most of the protection against sunlight was
provided by the thickness of the stratum corneum [2,3]. This point has
been re-emphasized today.
The Transfer, Degradation, and Excretion of Melanin That melanin
was synthesized exclusively by epidermal melanocytes was not
appreciated until the 1930’s. Because basilar keratinocytes had so much
melanin within their cytoplasm, originally it was thought that they were
capable of synthesizing this pigment. This latter idea was abandoned and
the concept of transfer of pigment became universally accepted [5].
Melanin could be found in epidermal keratinocytes, but also in dermal
melanophores, lymph nodes, and so on. It was thought that sunlight
caused rapid transit of pigment from the basilar layer of the epidermis to
the stratum corneum from where it was excreted by desquamation. Most
investigators also thought that melanin normally was transported via
melanophores to lymph nodes, liver, and spleen, and eliminated in the
urine or via the intestinal tract. It is surprising that little more is known
today about the process of melanin degradation and excretion.
Regulation of Melanocyte Function and Proliferation Sunlight was an
obvious stimulant of pigment cell function because it produced tanning.
Tanning from melanin synthesis was observed 3–5 d after exposure to
sunlight and was distinguished from immediate pigment darkening (the
Mierowsky phenomenon). Immediate pigment darkening occurred with-
in hours after light exposure, occurred in cadavers, and could be induced
by heat as well as light filtered through window glass (UVA spectrum;
320–400nm) [2,3]. Mechanical injury, radiation of all types, and heat all
enhanced pigmentation. Investigators recognized that diseases of the
adrenal and pituitary gland were associated with hyperpigmentation,
although they could only speculate about the mechanisms for enhanced
pigmentation. It was suggested that the loss of sodium chloride associated
with Addison’s disease (adrenal insufficiency) accelerated the oxidation
of vitamin C in the skin. The loss of vitamin C could enhance melanin
formation. Stephen Rothman showed that the skin contained many
proteins with sulfhydryl side chains which inhibited the oxidation of
tyrosine to melanin. He also showed that sunlight depleted the epidermis
of sulfhydryl containing compounds. He suggested that melanin
formation was regulated by this mechanism [2,3].
Diseases of Pigmentation Vitiligo was thought by S. W. Becker to be a
functional impairment of melanocytes, not a destruction of the cell.
Malignant melanoma was poorly described and not differentiated from
the benign Spitz nevus (juvenile melanoma). Piebaldism was not well
understood. It was noted that only one of the Dionne quintuplets, all five
of whom were thought to be monozygotic, had a moderately large
congenital nevus. Thus, congenital nevi were thought not to be
genetically determined.
Melanocyte Function: Cell/Cell Interactions Melanin was known to be
an oxygen scavenger but not a great sunscreen. However, it was
recognized that blacks had fewer skin cancers. Epidermal pigment cells
clearly transferred melanin into keratinocytes, but the biochemical
signals causing this transfer were not known. As noted above, Langerhans
cells were considered to be dying pigment cells.
1950–1975: INTRODUCTION OF MOLECULAR AND
CELLULAR BIOLOGY INTO PIGMENTATION
The Names of Pigment Cells In the 1950’s, the terminology of the
pigment cell system changed slightly. A melanoblast, formerly a pigment
producing cell, was redefined as a precursor cell that can differentiate
into a mature cell capable of synthesizing melanin. The mature cell was
renamed a melanocyte [6]. Melanophore was a term reserved for dermal
pigment cells that are found only in lower vertebrates and which were
responsible for the rapid color changes exhibited by these animals [7].
Melanophages were defined as dermal macrophages laden with
melanin [8,9].
The Embryologic Origin of Melanocytes It was shown that the neural
crest, especially the cranial portion, was the embryologic anlage for many
mesenchymal tissues of the head and neck, i.e., the bones, cartilage, and
muscles of the face, as well as leptomeninges and portions of the cardiac
conduction system. These data provided a hypothetical basis for under-
standing complex pigmentary syndromes such as the multiple lentigines
syndrome. In addition, work by Beatrice Mintz elegantly demonstrated that
melanocytes migrating from the neural crest followed dermatomal path-
ways [10].
Melanin Producing Cells: Melanocytes The newly named melanocyte
was the cell responsible for the synthesis of all melanin [5,6,11,12]. That
epidermal pigment cells synthesized melanin throughout life, whereas
dermal melanocytes, uveal, and retinal pigment epithelial cells did not,
was first recognized in the 1950’s. Thomas Fitzpatrick proposed the
concept of the epidermal melanin unit, i.e., one melanocyte providing
melanin to about 35 keratinocytes [6,13].
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By electron microscopy it was recognized that melanin was packaged
in melanosomes that had a very precise substructure. M. Seiji first
proposed the term melanosome for this cytoplasmic organelle (Fig 1) and
suggested that melanosomes were formed by the fusion of vesicles from
the smooth endoplasmic reticulum and the Golgi apparatus [14]. He
suggested that tyrosinase was synthesized in the rough endoplasmic
reticulum. The tyrosinase containing vesicle fused with particles and
other vesicles and became activated. That epidermal pigment cells
always were adjacent to the epidermal basal lamina and were free of
desmosomal attachments was also noted by electron microscopy. Other
ultrafine details of the nuclei, mitochondria, and cellular substructure
were described.
Attempts to determine whether the enzymes of the glycolytic
(Embden-Meyerhoff) and the Krebs citric acid cycle were present in
melanosomes were impeded by the problem of separating melanosomes
and mitochondria [2,3,15]. The electron microscope permitted investi-
gators to monitor the separation process. Although glycolytic oxidative
enzymes were not found in melanosomes, other enzymes like acid and
alkaline phosphatases, which are characteristics of lysosomes, were
found. Melanosomes may be one type of lysosome.
George Szabo completed studies that showed that the difference
between dark and lightly colored skin was the quantity of melanin. In
black skin, melanocytes form numerous large melanosomes. In white
skin, pigment cells produce smaller and partially melanized melano-
somes. However, white skin could be induced to produce larger and
more fully pigmented organelles by exposure to sunlight [5,16].
Langerhans cells were still relegated to the garbage heap as dying
melanocytes.
The Melanin Pathway A. B. Lerner first showed that one enzyme could
catalyze the first two steps in the melanin pathway (Fig 2); that is, one
enzyme could function both as tyrosine hydroxylase and dopa oxidase
[17]. For simplicity, this enzyme was called tyrosinase despite its dual
function. Lerner and T. B. Fitzpatrick isolated the enzyme and showed
that dopa was a necessary cofactor to accelerate the oxidation of
tyrosine to dopa. Eventually, multiple forms of tyrosinase were identified
(Fig 3) [18].
That tyrosine, not dopa, was the normal substrate [19] for the
ptroduction of melanin in man was shown by clinical observations on
children with the disease phenylketonuria. Phenylalanine competes for
the binding site of tyrosine and inhibits the function of tyrosinase.
Children with phenylketonuria are albinoid and have very light colored
hair. Removal of phenylalanine from their diet and substitution with
tyrosine not only improves their health, but also returns the color of their
skin and hair to normal.
New intermediary steps in the conversion of tyrosine to melanin were
identified during this time [19]. The Raper-Mason pathway became
longer and more complex. Oxidation of tyrosine to melanin was found to
require release of at least one molecule of CO2 and the removal of four
electrons from tyrosine.
Melanin Polymer The structure of melanin was still unproven, although
most investigators suggested that the pigment was a heteropolymer
formed by condensation of many intermediary metabolites in the
melanin pathway. Mason argued strongly that melanin was a homo-
polymer [20]. Giuseppi Proto and his co-workers in Italy distinguished
two pigments, eumelanin and phaeomelanin. Eumelanin is black, brown,
or yellow in color and is formed exclusively from tyrosine. In contrast,
phaeomelanin is a red pigment and is formed from two amino acids,
tyrosine and cysteine. Cysteine condenses with dopaquinone to form
cysteinyl dopa. Cysteinyl dopa is the precursor for phaeomelanin. Later,
Prota showed that in all human melanin there was a mixture of both
phaeo and eumelanin [27]. Blacks formed predominantly eumelanin,
Celtic individuals a larger proportion of phaeomelanin.
Melanin Transfer, Degradation, and Excretion Microfilaments com-
posed of actin and myosin and microtubules which formed the
cytoskeleton of dermal melanophores in amphibian skin are required
for the translocation of melanosomes in and out of dendrites. In human
pigment cells, 10 nm intermediate filaments appear to be responsible for
the transfer of melanosomes from the perinuclear region to the tip of the
dendrites. Intercellular transfer of melanosomes is accomplished by
phagocytoses of the tip of the dendrites containing melanosomes by the
adjacent keratinocytes (Fig 4) and later digested so that the melanosomes
can disperse through the cytoplasm of the keratinocyte [22]. Many large
melanosomes are found in keratinocytes of black skin [23]. Smaller
melanosomes are retained in the cytoplasm of the melanocytes in white skin.
Regulation of Melanocyte Differentiation and Growth In the 1950’s,
Aaron Lerner and Kazuo Shizume isolated alpha-MSH (13 amino acid)
from bovine pituitary glands and determined its structure [24], Later, Teh
Lee [25] isolated a second pigmenting hormone, beta-MSH (17 amino
acid). Both of the hormones induced rapid alterations of skin color in
amphibians [26,27]. This was due to translocation of melanosomes
Figure 1. Diagram showing development of melanin granules in the melanocyte. Melanin granules are distinct cytoplasmic constituents of the melanin forming
cell and have their own characteristic enzyme (tyrosinase). The term ‘‘melanosome’’ is proposed for the distinctive, enzymatically active particle which is the
site of melanin formation and is located within the cytoplasm of the melanocyte [14].
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within dermal melanophores. M Hadley showed that MSH could also
increase melanization by epidermal pigment cells in these same animals.
MSH, and to a lesser degree ACTH, injected into humans for weeks or
months did stimulate an increase in pigmentation, although MSH molecules
were far less potent in humans than in the amphibian system [28,29].
Lerner also isolated melatonin from the pineal glands [35]. It rapidly
reversed the effects of MSH on dermal melanocytes in frog skin [30].
However, melatonin, named for its ability to lighten amphibian skin, had
no effect on human skin color. It does have critical importance for the
regulation of pituitary function, and its secretion is regulated by the
intensity of ambient sunlight. Julius Axelrod won the Nobel Prize in the
early 1970’s for his work on on pineal function and its synthesis of
melatonin and other hormones.
Richard Snell showed that the various MSH molecules had very
different potencies in different animal species. He also demonstrated that
thyroxine, androgens and estrogens could increase pigmentation. The sex
hormones had particularly potent effects on sexually related skin such as
the genitalia, areola, and nipples.
Glenda Wong first observed that the cultures of murine Cloudman
S91 melanoma cells obtained from the American Tissue Type Collection
could respond to MSH [31]. Wong and Pawelek, using the S91
Cloudman melanoma line, demonstrated that MSH bound in the
membrane of the cells activated the enzyme adenylate cyclase which
formed cyclic AMP (cAMP). cAMP, an intercellular messenger, activated
a second enzyme, protein kinase. Thereafter, an unidentified series of
events occurred which caused transcriptional and translational events
resulting ultimately in activation of tyrosinase. Pawelek postulated that
the new tyrosinase activity was principally it due to activation of pre-
formed enzyme [31]. Currently, it is thought that MSH both activates pre-
formed enzyme as well as induces de novo synthesis.
Pawelek observed that Cloudman melanoma cells grew more slowly
in the presence of MSH. He proposed that cAMP was a double signal,
i.e., it increased tyrosinase activity but decreased cellular proliferation.
He noted that in many of his mutant melanoma cell lines, cAMP was not
necessarily a signal for either function. This work brought pigmentation
to a molecular level [32,33].
Diseases of Pigmentation A major advance of clinical significance was
the classification of melanomas into nodular, superficial spreading
melanomas and lentigo maligna by G. McGovern and Wallace Clark
[34]. Later, a prognostic index (Clark levels) was proposed and found to
correlate accurately with the clinical course of patients with melanomas.
This has been partially superceded by the system described by Alexander
Breslow and measures the thickness of a melanoma with an ocular
micrometer. The Breslow system as a single parameter is a somewhat
more accurate indicator for predicting the five-year survival of patients
with melanoma or recurrence rates. Clinicaly, it seems that the best
information is a recombination of both the Clark level and the Breslow
thickness. Vitiligo was shown to be a destruction in the elimination of the
melanocytes from the depigmented areas of skin [36]. Psoralens were
recommended for treatment of vitiligo [55]. Some types of oculocuta-
neous albinism were proven to be due to defects in the tyrosinase
enzyme (absence of, or aberrant processing of the enzyme), not due to a
loss or lack of melanocytes (Fig 5) [37]. In contrast, piebaldism [38] was
found to be due to a genetically determined absence of melanocytes from
the unpigmented patches [36].
The Function of Melanocytes; Cell/Cell Interactions Little work was
done on this topic until the 1980 s. However, Inga Silberberg published
her first article implicating the Langerhans cell in contact dermatitis in
guinea pigs. The concept was rejected by many pigment cell biologists
who considered the cell an effete melanocyte. The relationship of
melanocytes and Langerhans cells remained a dilemma [39].
1975–1987: THE MODERN ERA
Names of Pigment Cells No changes in the terminology have occurred
in the last thirty years [40].
Figure 2. Enzymatic oxidation of tyrosine to melanin [17].
Figure 3. Patterns of proteins (a) and active tyrosinase (b) extracted from
human metastatic malignant melanoma. Patterns of activity of soluble (c) and
macromolecular (d) tyrosinase derived from Harding-Passey mouse
melanoma as shown by acrylamide-gel electrophoresis. As oriented here, the
enzyme migrated from the bottom (cathode) to the top (anode) of the gel [18].
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The Embryonic Neural Crest Origin of Melanocytes From the work of
Karen Holbrook, it is now recognized that in humans melanocytes begin
to migrate from the neural crest as early as 2.5 weeks post-fertilization.
The cells are first found in the dermis and arrive in the epidermis around
8–10 weeks. Melanosomes and small amounts of melanin can be found
by electron microscopy shortly thereafter [40]. The cells do not actively
produce melanin until after birth except in some areas like the genitalia
and nipples [41]. At birth these sites are deeply pigmented. Presumably
this pigmentation is due to the steroidal stimulation of sex specific skin
induced by hormones from the mother.
The eyes also have a full complement of pigment cells at birth [41].
Those in the retinal pigment epithelium come from the primitive
forebrain, not the neural crest. They are replete with melanin by 8–10
weeks of gestation. Melanin in the retinal pigment is now thought to be
the embryologic inducer for normal development of the fovea and optic
nerves. Lack of melanin in the eyes during the first trimester is thought to
be the cause of the ocular dysfunction and foveal hypoplasia diagnostic
of oculocutaneous albinism.
Choroidal melanocytes which come from the neural crest in humans
do not initiate melanin formation until the third trimester of gestation and
may continue to produce melanin and cause darkening of the iris of an
individual until early adulthood [41].
Melanin Producing Cells: Melanocytes Melanosomal formation and
tryosinase transport were described in more detail (Fig 6) [42,43].
Melanosomes containing phaeomelanin are round and have an irregular
substructure. Eumelanosomes are oval in shape and have a very orderly
substructure. All pigment cells can produce either type of melanosome or
melanin, although the switch mechanism for this has not been well
identified.
Figure 4. Cytoplasmic projections of the cortical cell extend from the cell body and wrap around the tip of the melanocyte dendrite (a) which is later pinched off
and completely enclosed within the cortical cell cytoplasm (b). The pinched-off portion of the dendrite exists for a period of time in the cortical cell cytoplasm
enveloped by its own membrane and that of the cortical cell (c and d ) [22].
Figure 5. a: Human albino hair root, control, b: Human albino hair root,
after incubation in tyrosine solution for 24 h; pigmentation is confined to
region of lower matrix where melanocytes are normally present, c: Pigmented
dendritic cells in unstained albino epidermis after incubation in tyrosine [37].
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Tyrosinase is translated on ribosomes of the rough endoplasmic
reticulum. The core tyrosinase molecule is transported to the Golgi
apparatus where its carbohydrate moieties are modified. At the trans face
of the Golgi apparatus, the tyrosinase is already capable of giving a
positive dopa reaction, i.e., synthesizing melanin. In the Golgi apparatus,
tyrosinase is glycosylated. Complete glycosylation seems critical for
translocation of tyrosinase into Golgi-derived coated vesicles and for
fusion with premelanosomes formed from the smooth endoplasmic
reticulum. Fusion of the two vesicles puts active tyrosinase into the
melanosome [41]. Tyrosinase converts tyrosine to dopa very slowly at pH
of 6.8 or above. Recent evidence indicates that at lower pH the reaction
is much more rapid. Results of preliminary work indicate that the
melanosomal pH may be significantly lower than previously thought.
Thus, tyrosinase activity may be determined in part by the pH of the local
environment within the cytoplasmic organelle.
The source of melanocytes in hair bulbs is mysterious. Telogen hairs
normally fall out and are replaced by anagen hairs which retain their
normal color. At older age, such hairs become gray. Some melanocytes
are shed within the hair itself. Do melanocytes dedifferentiate and remain
in the dermis or epidermis until the new hair grows? Or is there a pool of
melanoblasts residing in the dermis near the hair bulb ready to
repopulate the new hair? This is a persisting enigma. It is interesting
that one patient with silver-white hair received electron beam for
mycosis fungoides. He lost hair in those areas exposed to radiation.
When the hair regrew, it was pigmented. This observation suggests that a
pool of primitive melanoblasts residing within the skin and was activated
by the X radiation.
By the late 1970s it became abundantly clear that Langerhans cells
and pigment cells were different and the former had unique immunologic
functions. By 1987, new data suggested that pigment cells interacted
closely with both the Langerhans cell and keratinocyte [44,45].
A major advance was the serendipitous discovery by M. Eisinger that
normal human melanocytes grew rapidly and vigorously in the presence
of phorbol esters and cholera toxin [46,47]. Other investigators have
used extracts from various tissues, e.g., the hypothalamus, and growth
factors such as basic fibroblast growth factor rather than phorbol ester to
grow melanocytes in culture.
Melanin Pathway The intermediary steps in the conversion of tyrosine
to melanin were more precisely defined [48]. A second enzyme was
identified, namely, dopachrome oxido reductase. This enzyme acted as a
dopachrome conversion factor as well as an indole blocking factor. It
converted dopachrome to 5,6-dihydroxyindole and in the absence of
tyrosinase inhibited the oxidation of dihydroxyindole to indolequinone.
In addition, tyrosinase has been shown to be active in a third reaction
involving the oxidation of 5,6-dihydroxyindole to 5,6-indolequinone,
which subsequently formed melanin. The existence of other non-
enzymic regulators such as Caþ þ and other factors within the melanin
pathway have been postulated in order to explain the multiple types of
albinism (9 types) in which patients have adequate quantities of active
tyrosinase enzyme but form melanin very slowly.
Multiple glycosylated forms of tyrosinase have been identified and are
capable of giving a positive dopa reaction. The smaller molecule (68 kd)
is thought to be a precursor of the final mature and active molecule, an
81.2-kd protein. Several investigators have indicated that they have
isolated and are working on identifying the sequence for the tyrosinase gene.
The Melanin Molecule It is now agreed that melanin is a hetero-
polymer. However, its precise structure, if constant, is not known. The
question whether animal, plant, and synthetic melanin are similar
remains to be determined. Phaeomelanin is rapidly degraded by
ultraviolet light and releases free oxygens [49]. Eumelanin is more
photostable.
Melanin Transfer, Degradation, and Excretion Culture of melanocytes
indicates that they are very active cells synthesizing melanin and moving
their dendrites hither and there. The cells are mobile in vitro and can be
induced to migrate also in vivo. For example, repigmentation of patients
with vitiligo involves migration of melanocytes primarily from hair
follicles. Keratinocytes also are active partners in melanin transfer. In
tissue culture, it is clear that keratinocytes are very actively phagocytic.
They will phagocytize polystyrene beads or isolated melanosomes. Thus
it is likely that the keratinocyte and epidermal pigment cell communicate
actively during the melanin transfer process. Signals for this are
unknown.
Regulation of Melanin Formation MSH is the classic melanotropic
hormone [50]. It is produced by the synthesis of a large peptide,
proopiomelanocortin, in the pituitary. The latter peptide has 256 amino
acids and is cleaved in the pituitary into a variety of bioactive
compounds including a-MSH, ACTH, b-lipotrophin, enkephalins, and
endorphins [56]. Beta-MSH probably is not a biologically relevant
molecule in humans [51,52].
It is unclear how physical types of energy, for example, electron
beams or electromagnetic irradiation (UV light) [53], stimulate melanin
formation or pigment cell growth. It is known that keratinocytes store 7-
dehydrocholesterol. Recent work indicates ultraviolet light photoisome-
rizes 7-dehydrocholesterol into cholecalciferol. This latter compound
activates the enzyme phospholipase A2 and causes liberation of
arachidonic acid. Cholecalciferol is later converted into vitamin D.
Arachidonic acid is converted to prostaglandins and leukotrienes or other
metabolites.
Recently a vitamin D receptor has been isolated from normal human
melanocytes. The receptor binds specifically 1,25-dihydroxy vitamin D3.
The dihydroxylated vitamin D and 25-hydroxy vitamin D3 suppress
tyrosinase activity of human melanocytes growing in the very artificial
media containing phorbol esters, cholera toxin, and other agents. What
effect vitamin D has on epidermal pigment cells in normal human skin is
not clear. Many investigators have suggested 1,25 dihydroxy vitamin D3
is involved in regulation of melanin synthesis. It has also been suggested
that melanin content determines the amount of UV required for optimal
vitamin D3 synthesis in the epidermis [51].
Arachidonic acid stimulates epidermal proliferation and melanin
synthesis. This effect is mimicked by oleic acid, an indicator that fatty
acids have a direct effect on epidermal pigment cells. That the effects of
arachidonic acid are partially, albeit significantly, blocked by indo-
methacin suggests that some of the observed results are mediated by
prostaglandins. The proliferation of epidermal pigment cells induced by
Figure 6. Diagram summarizing major events in the early development of
melanocytes, their subsequent differentiation, and interaction throughout life.
G: Golgi apparatus; E: endoplasmic reticulum; N: nucleus; M: mitochondria;
PMS: early melanosome; MS: fully melanized melanosome; I, II, III, and IV:
stages in melanosome development, shown in upper left corner of dendritic
process [43].
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ultraviolet light is also blocked by indomethacin. It seems that
prostaglandins affect pigment cells in the epidermis. Application of
PGE to murine skin stimulates both proliferation and melanization [51].
In vitro, PGE is one of the most potent activators of tyrosinase in
murine Cloudman melanoma cells, more so than a-MSH. However, it
retards proliferation. Prostaglandin E does increase intracellular cyclic
AMP. This and other extensive data confirm that cAMP cannot be both a
signal for melanization as well as control of proliferation [57]. PGE
retards cell growth of Cloudman cells. PGE may be producing its effect
by holding cells in the G2 phase of the cell cycle. Others have shown that
it is in G2 phase of the cell cycle that the MSH receptor is expressed.
Possibly in vivo a noxious agent stimulates PGE formation which pushes
cells into G2 and initiates melanogenesis. In G2, MSH receptors would
be unveiled. MSH would then enhance the stimulatory effect and cause
production of melanin. Anthony Thody has suggested that beside the
pituitary gland, the epidermis might be a site for MSH synthesis.
It is now known that alpha-MSH is an antagonist for interleukin 1, a
critical early activating signal for the immune response. Interleukin 1 in
the hypothalamus induces fever by activating formation of prostaglandin
E. In the liver, interleukin 1 causes release of acute phase reactants. For
lymphocytes, interleukin 1 is necessary for initiation of immune
response. Alpha-MSH blocks all of these effects. Every cell in the
epidermis, keratinocytes, melanocytes, and Langerhans cells, synthesize
interleukin 1 and/or an interleukin 1-like molecule called ETAF.
Application of alpha-MSH to the skin abrogates its immune functions.
This MSH induced block is reversible by interleukin 1/ETAF, an
indication that within the skin there is a competitive interchange
between MSH and interleukin 1 [58]. Conversely, ETAF totally blocks
the melanogenic effect of MSH on Cloudman melanoma cells. The
normal enhancement of melanization and tyrosinase activity induced by
MSH is completely reversed by low concentration of ETAF [59]. This
further suggests that cells of the epidermis must have a very intricate
signaling system.
Diseases Identification of the pathophysiology [54] and the treatment of
pigmentary disorders lags far behind our knowledge of the cellular and
molecular biology of the pigmentary system.
Function of Melanocytes; Cell-Cell Interactions We believe melano-
cytes are one of the three cells in the epidermal tripod. The three cell
types interact closely. Most inflammatory processes such as ultraviolet
light, psoralens plus UVA (PUVA), the oxidation of arachidonic acid to
prostaglandin and leukotrienes, the oxidation of pro-carcinogens by the
aryl hydrocarbon hydroxylase system — each of which of which is a
potent melanogenic agent — also produce toxic Oxygens. We suggest
the melanocyte function is to remove these toxic oxygens from
surrounding cells and convert them into an inert molecule called
melanin. Melanin itself can be and is an oxygen scavenger and a
sunscreen. But the more important aspect is the ability of the melanocyte
to remove the mutagenic and carcinogenic toxic oxygen from the
surrounding keratinocytes and Langerhans cells. Melanin in dark skin is
only an indicator of the effectiveness of this process. We suggest that the
melanocyte-keratinocyte-Langerhans cell tripod must work closely
together for optimal homeostasis in the epidermis.
THE FUTURE: SOME UNRESOLVED PROBLEMS
The following problems need to be resolved in the future: 1)
Identification and isolation of the MSH receptor and the role of MSH
in melanocyte function; 2) Identification and isolation of the prostaglan-
din receptor; 3) Identification and isolation of the epidermal thymocyte
activating factor (ETAF) receptor; 4) Determination of the mechanisms by
which ETAF inhibits the response of melanoma cells (i.e., increase
melanin synthesis) to melanogenic agents such as MSH; 5) Precise
identification of the mechanism for the transcription of enzymes and
structural proteins needed for melanosomal formation and translocation
of tyrosinase from the Golgi apparatus into the pre-melanosome; 6) The
role of PGE in the control of cellular proliferation and alteration of
melanocyte cell cycle, and the implications of these effects on tyrosinase
stimulation; 7) The role of vitamin D in melanization; 8) The role of
pigment cells in epidermal homeostasis in response to noxious agents; 9)
Determination of the structure(s) of melanin; 10) Production of better
treatments for pigment cell disorders based on the cellular and molecular
biology of the system, i.e., melanoma, vitiligo, etc; 11) Determination of
the mechanism for degradation of melanin within the epidermis; 12)
Identification of other regulatory factors in the melanin synthetic pathway
which might explain disorders such as albinism.
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